ClinicalTrials.gg
Drug

Terlipressin clinical trials

Also written Glypressin.

Includes 1 study of Terlipressin acetate.

studies test it
64
open now
11
in phase 3
15
first study started
2002

How each study uses Terlipressin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Terlipressin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Sept 2022 · TERLIVAZ · NDA 022231 (FDA, Drugs@FDA; as terlipressin acetate)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Terlipressin
53
carbitocin
3
Novapressin
2
Terlipressin Injectable Product
2

Other names

Glypressin
10

In one entry with another drug

Given together, or one or the other

Terlipressin and albumin
2

Studies by the year they started

64 studies that test it; most in 2022 (7)

Studies that test Terlipressin, by start year
YearStudies
20021
20043
20063
20072
20081
20092
20101
20124
20134
20142
20152
20165
20172
20185
20193
20205
20212
20227
20233
20242
20254
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
16
Phase 3
15
Phase 4
15
No phase
21

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 57

Institute of Liver and Biliary Sciences, India (9) · Wael Elbanna Clinic (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4) · Assiut University (3) · Mallinckrodt (3) · Hospital Clinic of Barcelona (3) · Aga Khan University (3) · Assistance Publique - Hôpitaux de Paris (2)

Often tested with

Tested in the same studies.

Norepinephrine (5) · Octreotide (3) · Somatostatin (2) · Albumins (2) · Tranexamic Acid (1) · Serelaxin (1) · Arginine Vasopressin (1) · Carbetocin (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Terlipressin.

Studies

Open first, then newest update. How each study uses Terlipressin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 64

See all 64 studies that test Terlipressin →

Given beside what is tested · 2 — Terlipressin is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Terlipressin

Codes

What other systems call Terlipressin · ClinicalTrials.gg INT006762

  • MeSH (NLM) D000077585TerlipressinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 7Z5X49W53PTERLIPRESSINConfirmed FDA, NLM
  • RxNorm 57048One source FDA
  • NCI Thesaurus C77387TerlipressinOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.